Search research articles
Contact Us
Filters
Showing results (1-10 of 74) with videos related to
Page
of 8
Sort By:
Rheumatology International
|
January 20, 2021
Arthritis in the hands of saints
Nicholas Manolios
Internal Medicine Journal
|
August 23, 2018
Coturnism
Nicholas Manolios
Seminars in Arthritis and Rheumatism
|
October 1, 2005
Proteomics in rheumatology: a new direction for old diseases
Marina Ali, Nicholas Manolios
Annals of the Rheumatic Diseases
|
January 28, 2021
Correspondence on 'Glucosamine and O-GlcNAcylation: a novel immunometabolic therapeutic target for OA and chronic, low-grade systemic inflammation?'
Socrates Angelides, Nicholas Manolios
Annals of the Rheumatic Diseases
|
March 25, 2018
Checkpoint inhibitors and arthritis
Nicholas Manolios, Leslie Schrieber
European Journal of Rheumatology
|
November 23, 2017
The endocannabinoid system in pain and inflammation: Its relevance to rheumatic disease
Nicola Barrie, Nicholas Manolios
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
|
February 1, 2023
Anti-inflammatory Effects of First-line Anti-arthritic Drugs on T-cell Activation
Nicholas Manolios, Guojiang Hou
Molecular Immunology
|
October 5, 2007
Hypothesis: TCR signal transduction--A novel tri-modular signaling system
Michael A Amon, Nicholas Manolios
The Medical Journal of Australia
|
October 8, 2009
Systemic sclerosis: new hope for an unyielding disease
Helen J Englert, Nicholas Manolios
Cell Adhesion & Migration
|
May 1, 2010
T-cell antigen receptor (TCR) transmembrane peptides: A new paradigm for the treatment of autoimmune diseases
Nicholas Manolios, Marina Ali, Vera Bender
Page
of 8
Search research articles
Search
Showing results (1-10 of 74) with videos related to
Sort By:
Page
of 8
Rheumatology International
|
January 20, 2021
Arthritis in the hands of saints
Nicholas Manolios
Internal Medicine Journal
|
August 23, 2018
Coturnism
Nicholas Manolios
Seminars in Arthritis and Rheumatism
|
October 1, 2005
Proteomics in rheumatology: a new direction for old diseases
Marina Ali, Nicholas Manolios
Annals of the Rheumatic Diseases
|
January 28, 2021
Correspondence on 'Glucosamine and O-GlcNAcylation: a novel immunometabolic therapeutic target for OA and chronic, low-grade systemic inflammation?'
Socrates Angelides, Nicholas Manolios
Annals of the Rheumatic Diseases
|
March 25, 2018
Checkpoint inhibitors and arthritis
Nicholas Manolios, Leslie Schrieber
European Journal of Rheumatology
|
November 23, 2017
The endocannabinoid system in pain and inflammation: Its relevance to rheumatic disease
Nicola Barrie, Nicholas Manolios
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
|
February 1, 2023
Anti-inflammatory Effects of First-line Anti-arthritic Drugs on T-cell Activation
Nicholas Manolios, Guojiang Hou
Molecular Immunology
|
October 5, 2007
Hypothesis: TCR signal transduction--A novel tri-modular signaling system
Michael A Amon, Nicholas Manolios
The Medical Journal of Australia
|
October 8, 2009
Systemic sclerosis: new hope for an unyielding disease
Helen J Englert, Nicholas Manolios
Cell Adhesion & Migration
|
May 1, 2010
T-cell antigen receptor (TCR) transmembrane peptides: A new paradigm for the treatment of autoimmune diseases
Nicholas Manolios, Marina Ali, Vera Bender
Page
of 8